The diagnosis of hepatitis C virus (HCV) infection by serologic and molecular biology techniques has revealed other viruses that can induce hepatitis after transfusion or through community-acquired infection [1] . This category of hepatitis is without serologic markers for known hepatitis virus infections (hepatitis viruses A -E), and henceforth is referred to as non-A-E hepatitis. Recently, a putative non-A-E hepatitis virus has been identified and named OB virus C (OBV-C) [2] . More recently, another such virus has been reported and named hepatitis 0 virus (HOV) [3] . OBV-C and HOV have 86% similarity in nucleotide sequences and 96%-97% similarity in amino acid sequences, which indicates that they are the same virus with possibly different genotypes. RNA of OBV-C or HOV has been reported in sera from patients with acute and chronic hepatitis and in sera from patients with fulminant hepatitis who were without evidence of infection with known hepatitis viruses [2] [3] [4] [5] .
The genomes of OBV-C and HOV are positive, singlestranded RNAs, as are those of members of the Flaviviridae family, and they particularly resemble the genome of HCV, albeit with too wide a sequence divergence to be classified as genotypes of HCV [2, 3] . Infection with OBV-C can be diagnosed by RNA detection by reverse transcription-polymerase chain reaction (RT -PCR) with nested primers deduced from the nonstructural (NS) 3 region [2, [4] [5] [6] .
Both OBV-C and HOV tend to coinfect with HCV in hepatitis patients and persons with risk factors for parenteral hepatitis virus infection [2, 3] . Hence, patients with hemophilia would be at increased risk of infection with these non-A-E hepatitis viruses. Therefore, patients with hemophilia in Japan were tested for OBV-C RNA, and the sequences were compared with those of OBV-C or HOV isolates occurring in Japan and reported from other countries.
Methods
Patients. During 1992 and 1993, 63 consecutive patients with hemophilia received care at the First Department of Internal Medicine, Teikyo University School of Medicine. All were men (32.4 ± 11.4 years old; range, 14-60). In the past, they had received imported coagulation factor concentrates that had not been heatsterilized. All of the patients had HCV RNA in serum, and they had chronic liver disease. Antibody to human immunodeficiency virus type I (anti-Tll'v-l ) was detected in 33 (52%) ofthe patients.
Determination ofGBV-CRNA by RT-PCR and sequencing. Total RNAs were extracted from the test serum (100 JLL) by use of an extraction reagent containing guanidinium isothiocyanate and phenol (ISOGEN-LS; Nippon Gene, Tokyo) and dissolved in 5.3 JLL of distilled water treated with diethylpyrocarbonate (Sigma, St. Louis). They were heated at 70°C for I min, chilled quickly on ice, and subjected to cDNA synthesis with a cloned reverse transcriptase of Moloney murine leukemia virus (Superscript II; GIBCO BRL, Gaithersburg, MD) and an antisense primer (G75) with a sequence of 5'-CCTATTGGTCAAGAGAGACAT-3'. Reverse-transcribed cDNAs were heated at 95°C for 15 min, and a half portion was subjected to the first round of peR with sense primer G58 (sequence, 5'-CAGGGTTGGTAGGTCGTAAATCC-3') and primer G75 for 35 cycles (94°C at 30 s, 55°C at 30 s, noc at 60 s [8 min in the last cyclej), One-tenth of the amplification product of the first-round PCR (242 bp) was subjected to the second round of PCR with nested primers G134 (sense), with a sequence of5'·GGTCAYCYTGGT-AGCCACTATAGG-3' (Y = Cor T), and G131 (antisense), with a sequence of5'-AAGAGAGACATTGWAGGGCGACGT-3' (W = A or T), for 25 cycles under the same conditions as in the first round to amplify a fragment of 208 bp. All the primers were deduced from conserved areas of the 5' untranslated region (UTR) of the GBV-C or HGV genomes retrieved from databases-(GenBank/EMBLIDDBJ accession numbers: U36380, U44402, U45966, D90600, and D90601).
The samples testing positive for GBV-C RNA were subjected to RT-PCR with hemi-nested primers (G8 and Gil) as previously described [4] to determine a sequence of 100 bp in the NS3 region.
HCV RNA and genotypes. HCV RNA was determined by RT-PCR with nested primers deduced from conserved areas of the 5' UTR of the HCV genome [7] . The five common genotypes, designated I, II, III, IV, and V, were determined by RT-PCR with genotype-specific primers deduced from the HCV core gene by a second-generation method of genotyping [8] . Genotype I corresponds to Ia, II to 1b, III to 2a, IV to 2b, and V to 3a in the classification of Simmonds et al. [9] . The compound names (i.e., IlIa, II/lb, III/2a, IV/2b, and V/3a) are used herein.
Serologic testing. Antibody to HCV (anti-HCV) was determined by ELISA (ELISA II; Ortho Diagnostic Systems, Tokyo). Hepatitis B surface antigen (HBsAg) was determined by passive hemagglutination (MyCell; Institute of Immunology, Tokyo), and anti-HIV-I was determined by particle agglutination (SERODIA' HIV; Fuji Rebio, Tokyo).
Phylogenetic analysis. A phylogenetic tree for GBV-C and HGV was constructed by the unweighted pair-group method with the arithmetic mean [10] , using a molecular evolutionary analysis system for DNA and amino acid sequences (treeupg of the ODEN programs, version 1.1.1; National Institute of Genetics, Mishima, Japan).
Statistical analysis. Differences in frequencies among groups were evaluated with Fisher's exact test.
Results
GBV-C RNA was detected in 15 (24%) of the 63 hemophiliac patients, a frequency significantly higher (P < .001) than that among blood donors (2/337, 0.6%) in Japan. All 63 patients were infected with HCV and had serum anti-HCV and HCV RNA. GBV-C RNA was detected in 8 (24%) of the 33 patients with anti -HIV-1, a frequency comparable to that among patients without anti-HIV-I (7/30, 23%). It was detected in 1 of 3 patients with HBsAg and in 14 (23%) of the 60 patients without HBsAg.
There were no appreciable differences in the distribution of hemophilia A and B, levels of alanine aminotransferase, or severity of liver disease between the 15 patients with GBV-C RNA and the 48 patients without it (table 1). All 4 patients with liver cirrhosis or hepatocellular carcinoma had no GBV-C RNA in serum.
Genotypes ofHCV were l/Ia in 23 patients (37%), II/Ib in 13 (21%), 1II/2a in 4 (6%), IV/2b in 7 (11%), and V/3a in 13 (21%). The remaining 3 patients (5%) had mixed genotypes: l/Ia and IIllb in 1 and l/Ia and IVl2b in 2. There were no appreciable differences in the distribution of HCV genotypes among the 15 patients with GBV-C RNA and the 48 patients without it (table 1) . Figure 1 is a phylogenetic tree that compares a 100-bp sequence in the NS3 region of GBV-C isolates from the 15 hemophiliacs with those of GBV-C and HGV isolates reported from various countries [2] [3] [4] 6] . With the exception of case Discussion All 63 patients with hemophilia had HCV RNA, 33 (52%) were positive for anti-HIV-1, and 15 (24%) had GBV-C RNA in serum. These results indicate that the hemophiliacs in Japan had been at increased risk for infection with bloodbome viruses, such as HCV, HIV, and GBV-C. The results also corroborate the report of Linnen et al. [3] , who found HGV RNA in sera from 9 (18%) of 49 patients with hemophilia.
Due to a high conservation of the 5' UTR sequence postulated for GBV-C, primers deduced from it are expected to be more sensitive at detecting GBV-C RNA than are those deduced from the other areas of the genome, such as the NS3 region [4, 6] . When 704 sera from blood donors and from hepatitis and hemodialysis patients were tested for GBV-C RNA by RT-PCR, 50 were positive with nested primers derived from the 5' UTR and 48 were positive with those from the NS3 region; the 2 sera positive only by 5' UTR primers had low titers of GBV-C RNA (unpublished observations).
It was not possible to evaluate the results of solitary infection with GBV-C, because all the patients were infected with HCV and had various degrees of chronic hepatitis C. The lack of appreciable differences in clinical and biochemical features among the 15 patients with and the 48 without GBV-C RNA suggests that GBV-C would not have serious hepatotoxic effects in these subjects. The exact hepatotoxicity of GBV-C needs to be evaluated in persons not infected with known hepatitis viruses, although most cases of community-acquired non-A-E hepatitis run a mild subclinical course [1] .
There have been lines of evidence suggesting that HCV and HIV were imported from foreign countries in the past when stringent disinfection of coagulation factor concentrates were not routine. Anti -HIV-1 is rarely detected in the general population in Japan, partly because illicit intravenous drug use is scarce there. HCV genotypes uncommon in Japan have been reported in patients with hemophilia [11, 12] . In the 63 patients we studied, genotype l/l a was detected in 23 (37%) and V/3a in 13 (21%); these genotypes are rare in Japan [13] .
Phylogenetic relatedness of GBV-C and HGV sequences has been used as molecular evidence for their transmission by blood transfusion [14] . A phylogenetic tree constructed on a 100-bp NS3 sequence in reported GBV-C and HGV isolates along with those from the 15 hemophiliacs in this study revealed three genetic groups and possibly another represented by the 15, the sequences clustered into three groups separated by an evolutionary distance of~0.1O. Sequences from cases 1-7 belonged to a group including GBV-C isolates reported by Simons et al. [2] , while those of cases 8 and 9 belonged to a group represented by the 2 HGV isolates reported by Linnen et al. [3] and some of those reported by Simons et al. [2] . Sequences of the other cases were on a third branch along with those from Japanese patients on maintenance hemodialysis or with fulminant hepatitis [4, 6] . . GBV-C isolates from 15 hemophiliacs were compared with 8 GBV-C isolates (GBV-C, GBV-C.l-GBV-C.7) reported by Simons et al. [2] , 3 (FH.l-FH.3) from Japanese patients with fulminant hepatitis [4] , 2 HGV isolates (HGV-PNF2161, HGV-JC) reported by Linnen et al. [3] , and 8 GBV-C isolates (JHD4, JHD7-JHDll, JHDI4, JHDI6) from Japanese patients on maintenance hemodialysis [6] . 
case 15 isolate, which were separated by a genetic distance of 0.10 from each other (figure 1). GBV-C isolates from some hemophiliacs clustered to make a group with those reported from foreign countries [2] , thereby pointing to transmission of GBV-C by imported coagulation factor concentrates that these patients had received in the past. It would be extremely likely that GBV-C would be transmitted parenterally (by blood transfusions [6] and by injection with blood products). This view is supported by a study by Aikawa et al. [15] in which there was a high prevalence of GBV-C in hepatitis C patients who used illicit intravenous drugs (12/49, 25%) and by a study by Linnen et al. [3] , who found a high prevalence ofHGV in drug intravenous users (20/60, 33%).
Since 1985, efficient methods have been used for the viral disinfection of coagulation factor concentrates. These methods are expected to be efficacious against not only HIV and HCV but also GBV-C. Therefore, Japanese hemophiliacs who have used only the disinfected coagulation factor concentrates would not have been exposed to GBV-C offoreign origin. Such speculation would be substantiated by surveying GBV-C in additional age-stratified hemophiliacs and by sequencing parts of the genome for comparison with those of foreign and Japanese GBV-C isolates.
